MetLife, Inc. (MET)

FairStock Score: 44/100 — MIXED

Key Financials

Strengths

• Diversified revenue streams across life insurance, annuities, group benefits, and asset management globally
• Low beta of 0.74 provides defensive characteristics during market volatility
• Market capitalization of $46.6B provides substantial scale and brand recognition
• Essential insurance products with recurring revenue characteristics
• Significant presence in high-growth Asian markets

Concerns

• Alarming Altman Z-Score of 0.15 indicates severe financial distress and insolvency risk
• Negative free cash flow of -$12.7B annually signals the business is burning cash despite profitability
• High debt-to-equity ratio of 2.26 limits financial flexibility and increases vulnerability to economic shocks
• Piotroski F-Score of 6/9 shows deteriorating financial quality across key metrics
• Razor-thin net margin of 3.47% reflects intense industry competition and pricing pressure

AI Analysis

MetLife presents a classic insurance paradox—a large, essential business trading below intrinsic value yet burdened by structural headwinds. At $70.77 with a P/E of 14.56, the valuation appears attractive on its surface. However, the Graham Number of $33.92 reveals dangerous undercurrents: a negative margin of safety of -108%, signaling the market prices in significant distress. The Altman Z-Score of 0.15 screams insolvency risk—this is a company in the financial danger zone. With a debt-to-equity ratio of 2.26, MetLife carries substantial leverage typical of insurers, but the negative free cash flow of -$12.7B annually is deeply concerning. That FCF yield of 15.2% is misleading; it reflects capital outflows, not sustainable returns. The ROE of 12% is mediocre for a financial services firm—barely above cost of capital. Most troubling is the Piotroski F-Score of 6/9, indicating deteriorating financial quality. The company operates in a competitive, commoditized insurance landscape with razor-thin margins (3.47% net). While MetLife's diversified segments—Group Benefits, Retirement Solutions, Asia operations—provide some defensive characteristics, and the low beta of 0.74 suggests stability, I see a business struggling with legacy liabilities and intense competition. The recent quarter's $809M net income on $23.3B revenue is underwhelming. This is not a business I'd want to own at any price given the balance sheet stress and structural challenges.

Bull Case

MetLife's low valuation at 14.56x earnings combined with essential insurance products could attract activist investors demanding shareholder-friendly capital allocation. A pivot toward higher-margin annuity and retirement solutions, particularly in Asia, could improve returns and justify a multiple rerating above 16-17x earnings.

Bear Case

The negative free cash flow and deteriorating Z-Score suggest MetLife faces mounting pressure from legacy liabilities and rising claims. Economic recession combined with rising mortality or disability claims could force dividend cuts and potential covenant violations, destroying shareholder value entirely.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer